Real-time enrollment status for this metastatic clear cell renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 5:19 AM UTC
| NCT Number | NCT07179770 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Clear Cell Renal Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of September 3, 2026: Clinical trial NCT07179770 is currently recruiting participants. This phase1 study for metastatic clear cell renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07179770 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07179770 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.